Slovak companies Noili and DNA ERA seek capital for further growth

Following initial growth capital from a fund managed by CB Investment Management, two young Slovak companies, DNA ERA and Noili, now have the opportunity to raise additional investment from private investors on Crowdberry's platform. The total value of the new capital, which will enable these startups to continue expanding into new markets and broaden their product portfolios, will reach almost €1.3 million. 

The investment fund managed by CB Investment Management (CB Growth ONE) focuses on supporting innovative Slovak companies with the potential to establish themselves and grow internationally. The fund has raised €14.2 million in capital for 21 companies to date, including Glycanostics, altFINS, Artzenal, SmartHead, Boataround and others. These companies have proven their ability to unlock and grow their potential, even across the Crowdberry ecosystem, which provides innovative and quick access to smart capital from private investors through an investment platform.

That is the case of the biotechnology company DNA ERA and the Slovak premium cosmetics brand Noili. Both of these brands bring an innovative approach to health care and a balanced lifestyle. Health protection, as well as access to information and knowledge about one's own body, play a key role in the prevention of many diseases and improving the quality of life. Pandemics, as well as the unsatisfactory state of healthcare systems, have naturally led to growing interest among the public in innovative solutions that help to complement the overall picture and information about one’s own body.

DNA ERA – Personalised services using DNA analysis to reveal health risks, predispositions and athletic potential

Slovak company DNA ERA, founded by geneticist Michaela Šišková and her husband, the mathematician Jakub Šiška, focuses on direct genetic analysis of DNA using its own software for data interpretation. Thanks to this, it can reveal predispositions to diseases, genetic risks and detect sporting potential. Currently, it has introduced a new tool for comparing sports genes in collaboration with professional athletes.